Overall, the number of PB leukocytes, total T cells, CD8+ T-cells, and tumor CLL cells, in blood, were all significantly increased in U-CLL compared with the two M-CLL patient groups, in the absence of significant differences between the later M-CLL groups (Table 2). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.